Search Within

Gary Schwartz

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (25)
Groups
  1. Department of Medicine (64)
  2. Sarcoma Service (64)
  3. Solid Tumor Oncology Division (64)
  4. GSK Faculty (29)
  5. Biostatistics Service (24)
  6. Epidemiology and Biostatistics (24)

More Groups

People
  1. Mark Dickson (40)
  2. Richard Carvajal (26)
  3. William Tap (26)
  4. Mary Keohan (21)
  5. Sandra D'Angelo (20)
  6. Cristina Antonescu (16)

More People

Years
  1. 2023 (1)
  2. 2018 (1)
  3. 2015 (2)
  4. 2014 (7)
  5. 2013 (20)
  6. 2012 (13)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Clinical Cancer Research (4)
  3. Cancer Research (3)
  4. British Journal of Cancer (2)
  5. Sarcoma (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (8)
  3. Wiley Blackwell (3)
  4. Hindawi Publishing Corporation (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of FOLFOX administered with flavopiridol (F) in patients with refractory solid tumors
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M. A.; Cane, L. M.; Dials, H. J.; Schwartz, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial
    Meeting Abstract

    Keohan, M. L.; Morgan, J. A.; D'Adamo, D. R.; Harmon, D.; Butrynski, J. E.; Wagner, A. J.; Schwartz, G. K.; Maki, R. G.; Demetri, G. D.; George, S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase 1 study of XL281, a potent and selective inhibitor of RAF kinases, administered orally to patients (pts) with advanced solid tumors
    Meeting Abstract

    Schwartz, G. K.; Yazji, S.; Mendelson, D. S.; Dickson, M. A.; Johnston, S. H.; Wang, E. W.; Shannon, P.; Pace, L.; Gordon, M. S.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Clinical results of a phase II study of sorafenib in patients (pts) with non-GIST sarcomas (CTEP study #7060)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M.; Schuetze, S.; Undevia, S.; Livingston, M.; Cooney, M.; Kraft, A.; Saulle, M.; Schwartz, G. K.; Maki, R. G.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save